Alpine Woods Capital Investors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.63M Sell
27,118
-130
-0.5% -$30.3K 1.59% 16
2025
Q4
$5.64M Sell
27,248
-510
-2% -$101K 1.34% 19
2025
Q3
$5.15M Buy
27,758
+73
+0.3% +$12.5K 1.2% 25
2025
Q2
$4.23M Sell
27,685
-1,372
-5% -$211K 1% 34
2025
Q1
$4.82M Sell
29,057
-1,715
-6% -$268K 1.21% 28
2024
Q4
$4.45M Sell
30,772
-15
-0% -$2.32K 0.84% 40
2024
Q3
$4.77M Sell
30,787
-543
-2% -$86.5K 0.84% 41
2024
Q2
$4.58M Sell
31,330
-175
-0.6% -$26K 0.71% 48
2024
Q1
$4.56M Sell
31,505
-15,673
-33% -$2.49M 0.9% 36
2023
Q4
$7.39M Sell
47,178
-2,107
-4% -$323K 1.11% 30
2023
Q3
$7.68M Sell
49,285
-14,244
-22% -$2.35M 1.24% 24
2023
Q2
$10.5M Sell
63,529
-2,034
-3% -$328K 1.64% 13
2023
Q1
$10.2M Sell
65,563
-5,211
-7% -$841K 1.54% 15
2022
Q4
$12.5M Sell
70,774
-4,873
-6% -$841K 1.82% 9
2022
Q3
$12.4M Sell
75,647
-1,188
-2% -$201K 1.68% 8
2022
Q2
$13.6M Sell
76,835
-811
-1% -$144K 1.71% 8
2022
Q1
$13.8M Sell
77,646
-2,686
-3% -$457K 1.45% 10
2021
Q4
$13.7M Sell
80,332
-5,447
-6% -$892K 1.36% 15
2021
Q3
$13.9M Buy
85,779
+3,704
+5% +$632K 1.48% 8
2021
Q2
$13.5M Sell
82,075
-3,212
-4% -$532K 1.4% 10
2021
Q1
$14M Sell
85,287
-114
-0.1% -$18.4K 1.56% 9
2020
Q4
$13.4M Sell
85,401
-14,323
-14% -$2.11M 1.64% 11
2020
Q3
$14.8M Sell
99,724
-647
-0.6% -$95.7K 2.24% 3
2020
Q2
$14.1M Sell
100,371
-1,815
-2% -$264K 2.72% 3
2020
Q1
$13.4M Buy
102,186
+3,870
+4% +$549K 2.98% 3
2019
Q4
$14.3M Sell
98,316
-1,560
-2% -$212K 2.72% 5
2019
Q3
$12.9M Sell
99,876
-742
-0.7% -$97.8K 2.38% 5
2019
Q2
$14M Sell
100,618
-576
-0.6% -$79.7K 2.91% 5
2019
Q1
$14.1M Sell
101,194
-962
-0.9% -$129K 3.08% 3
2018
Q4
$13.2M Sell
102,156
-1,550
-1% -$216K 3.16% 3
2018
Q3
$14.3M Sell
103,706
-1,451
-1% -$193K 2.95% 4
2018
Q2
$12.8M Sell
105,157
-16,920
-14% -$2.11M 2.78% 4
2018
Q1
$15.6M Sell
122,077
-176
-0.1% -$23.8K 0.83% 28
2017
Q4
$17.1M Sell
122,253
-1,269
-1% -$177K 0.85% 28
2017
Q3
$16.1M Sell
123,522
-10,500
-8% -$1.39M 0.82% 32
2017
Q2
$17.7M Buy
134,022
+2,117
+2% +$270K 0.95% 22
2017
Q1
$16.4M Sell
131,905
-771
-0.6% -$92.1K 0.87% 25
2016
Q4
$15.3M Buy
132,676
+2,012
+2% +$232K 0.84% 27
2016
Q3
$15.4M Sell
130,664
-5,017
-4% -$609K 0.85% 28
2016
Q2
$16.5M Sell
135,681
-4,623
-3% -$525K 0.98% 20
2016
Q1
$15.2M Sell
140,304
-6,175
-4% -$639K 0.88% 28
2015
Q4
$15M Sell
146,479
-4,800
-3% -$483K 0.81% 36
2015
Q3
$14.1M Sell
151,279
-2,200
-1% -$213K 0.77% 42
2015
Q2
$15M Buy
153,479
+1,500
+1% +$150K 0.76% 39
2015
Q1
$15.3M Sell
151,979
-300
-0.2% -$30.5K 0.78% 41
2014
Q4
$15.9M Hold
152,279
0.82% 39
2014
Q3
$16.2M Sell
152,279
-13,100
-8% -$1.36M 0.86% 36
2014
Q2
$17.3K Sell
165,379
-100
-0.1% -$10.1K 0.45% 33
2014
Q1
$16.3M Sell
165,479
-3,500
-2% -$324K 0.9% 36
2013
Q4
$15.5M Sell
168,979
-100
-0.1% -$9.22K 0.88% 38
2013
Q3
$14.7M Sell
169,079
-65
-0% -$5.83K 0.9% 35
2013
Q2
$14.5M Buy
+169,144
New +$14.4M 0.93% 44

Other funds holding JNJ

Alpine Woods Capital Investors's JNJ Position: Q1 2026 in Review

Alpine Woods Capital Investors reduced its Johnson & Johnson (JNJ) stake by 0.48% in Q1 2026, selling an estimated $30.3K and leaving 27,118 shares worth $6.63M. The position accounts for 1.59% of the portfolio, ranked #16.

Alpine Woods Capital Investors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.7M in Q2 2017. 4,621 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Alpine Woods Capital Investors held 27,118 shares of Johnson & Johnson worth $6.63M as of Q1 2026.
  • Alpine Woods Capital Investors sold 130 Johnson & Johnson shares in Q1 2026, an estimated $30.3K.
  • Johnson & Johnson made up 1.59% of Alpine Woods Capital Investors's portfolio in Q1 2026, its #16 holding.
  • Alpine Woods Capital Investors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Alpine Woods Capital Investors's Johnson & Johnson position peaked at $17.7M in Q2 2017.
  • 4,621 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Alpine Woods Capital Investors's 13F filing for Q1 2026, filed 27 May 2026.